Foundayo vs. Ozempic: How the New Pill Compares to the Most Popular GLP-1
April 3, 2026
Foundayo (orforglipron) is the first oral GLP-1 receptor agonist approved for type 2 diabetes and weight management, offering a daily pill alternative to Ozempic's [...]